EU Opens In-Depth Antitrust Investigation Into Align Technology’s Invisalign Sales Practices

According to GuruFocus, the Commission’s decision moves the matter into an extended review after concerns were raised about Align’s commercial practices in the European Economic Area. The publication reported that regulators will examine whether the company’s sales strategy may have restricted competition by encouraging or requiring customers to purchase multiple products together.

The investigation centers on whether Align used its position in the clear aligner market to promote adoption of its iTero intraoral scanners through potentially anticompetitive tying arrangements. EU competition authorities will assess whether those practices limited customer choice or disadvantaged competing scanner manufacturers.

The European Commission said the inquiry follows a complaint submitted by a competitor and will evaluate whether Align’s conduct breached EU antitrust rules designed to prevent companies with significant market power from distorting competition. The Commission emphasized that opening a formal investigation does not predetermine the outcome of the case.

Competition authorities in the European Union have increasingly focused on allegations involving tying and bundling practices, particularly when companies with strong positions in one market may be using that position to strengthen another business. Under EU competition law, dominant companies are prohibited from abusing their market position in ways that could reduce competition or harm consumers.

Align Technology develops the Invisalign clear aligner system and the iTero family of digital intraoral scanners, products that are widely used by orthodontists and general dental practitioners as part of digital orthodontic treatment workflows. The company says more than 22 million patients have been treated with Invisalign worldwide, and its business combines orthodontic treatment planning with digital scanning technologies.

According to Reuters, European regulators are specifically examining whether Align leveraged the popularity of Invisalign to encourage or require dental professionals to adopt iTero scanners, potentially making it more difficult for competing scanner manufacturers to compete in the market. The Commission has described the investigation as its first formal antitrust case involving the medical devices sector.

GuruFocus reported that the Commission’s extended review reflects the seriousness of the competition concerns and allows regulators to gather additional evidence before reaching a final determination. Such investigations can involve requests for information from market participants, reviews of internal company documents, and economic analysis of competitive effects.

A formal antitrust investigation does not constitute a finding of wrongdoing. Under EU procedures, companies under investigation have an opportunity to respond to the Commission’s concerns and present evidence before any final decision is reached.

The European Commission has not announced a timetable for completing the investigation. The inquiry remains ongoing, and regulators will continue gathering evidence before determining whether Align Technology’s commercial practices complied with EU competition rules.

Source: GuruFocus